BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Matsushita K, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Constipation and Incident CKD. J Am Soc Nephrol 2017;28:1248-58. [PMID: 28122944 DOI: 10.1681/ASN.2016060656] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet. Microorganisms 2020;8:E1862. [PMID: 33255763 DOI: 10.3390/microorganisms8121862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sumida K, Molnar MZ, Potukuchi PK, Hassan F, Thomas F, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int 2018;93:1207-16. [PMID: 29409725 DOI: 10.1016/j.kint.2017.11.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
3 Matsuyama M, Hirai K, Nonaka H, Ueda M, Morino J, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y. Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease. Front Med 2022;8:780127. [DOI: 10.3389/fmed.2021.780127] [Reference Citation Analysis]
4 Cases A, Cigarrán-Guldrís S, Mas S, Gonzalez-Parra E. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients 2019;11:E1263. [PMID: 31167346 DOI: 10.3390/nu11061263] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
5 Cosola C, Sabatino A, di Bari I, Fiaccadori E, Gesualdo L. Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health. Nutrients 2018;10:E808. [PMID: 29937486 DOI: 10.3390/nu10070808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Ohkuma T, Iwase M, Fujii H, Ide H, Komorita Y, Yoshinari M, Oku Y, Higashi T, Oshiro A, Nakamura U, Kitazono T. Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry. Clin Exp Nephrol 2021. [PMID: 34173920 DOI: 10.1007/s10157-021-02105-9] [Reference Citation Analysis]
7 Lim J, Park H, Lee H, Lee E, Lee D, Jung HW, Jang IY. Higher frailty burden in older adults with chronic constipation. BMC Gastroenterol 2021;21:137. [PMID: 33765938 DOI: 10.1186/s12876-021-01684-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Constipation and risk of death and cardiovascular events. Atherosclerosis 2019;281:114-20. [PMID: 30658186 DOI: 10.1016/j.atherosclerosis.2018.12.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
9 Kalantar-Zadeh K, Joshi S, Schlueter R, Cooke J, Brown-Tortorici A, Donnelly M, Schulman S, Lau WL, Rhee CM, Streja E, Tantisattamo E, Ferrey AJ, Hanna R, Chen JLT, Malik S, Nguyen DV, Crowley ST, Kovesdy CP. Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney Disease. Nutrients 2020;12:E1931. [PMID: 32610641 DOI: 10.3390/nu12071931] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
10 Takayama K, Maehara S, Tabuchi N, Okamura N. Anthraquinone-containing compound in rhubarb prevents indole production via functional changes in gut microbiota. J Nat Med 2021;75:116-28. [PMID: 33078328 DOI: 10.1007/s11418-020-01459-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA). The systemic nature of CKD. Nat Rev Nephrol 2017;13:344-58. [PMID: 28435157 DOI: 10.1038/nrneph.2017.52] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 21.2] [Reference Citation Analysis]
12 Nata N, Suebsiripong S, Satirapoj B, Supasyndh O, Chaiprasert A. Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial. Int J Nephrol Renovasc Dis 2021;14:313-9. [PMID: 34393499 DOI: 10.2147/IJNRD.S328208] [Reference Citation Analysis]
13 Biruete A, Shin A, Kistler BM, Moe SM. Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis. Semin Dial 2021. [PMID: 34708456 DOI: 10.1111/sdi.13030] [Reference Citation Analysis]
14 Camerotto C, Cupisti A, D'Alessandro C, Muzio F, Gallieni M. Dietary Fiber and Gut Microbiota in Renal Diets. Nutrients 2019;11:E2149. [PMID: 31505733 DOI: 10.3390/nu11092149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
15 Kalantar-Zadeh K, Rhee CM, Joshi S, Brown-Tortorici A, Kramer HM. Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes. Curr Opin Nephrol Hypertens 2022;31:26-35. [PMID: 34750331 DOI: 10.1097/MNH.0000000000000761] [Reference Citation Analysis]
16 Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep 2020;5:121-34. [PMID: 32043026 DOI: 10.1016/j.ekir.2019.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
17 Sumida K, Molnar MZ, Potukuchi PK, George K, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease. Clin J Am Soc Nephrol 2017;12:1941-9. [PMID: 28893924 DOI: 10.2215/CJN.02720317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 5.4] [Reference Citation Analysis]
18 Cosola C, Rocchetti MT, di Bari I, Acquaviva PM, Maranzano V, Corciulo S, Di Ciaula A, Di Palo DM, La Forgia FM, Fontana S, De Angelis M, Portincasa P, Gesualdo L. An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. Toxins (Basel) 2021;13:334. [PMID: 34063068 DOI: 10.3390/toxins13050334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP. Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease. J Ren Nutr 2021;31:361-9. [PMID: 32952006 DOI: 10.1053/j.jrn.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Takayama K, Takahara C, Tabuchi N, Okamura N. Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation. Sci Rep 2019;9:3833. [PMID: 30846728 DOI: 10.1038/s41598-019-40278-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
21 Sumida K, Dashputre AA, Potukuchi PK, Thomas F, Obi Y, Molnar MZ, Gatwood JD, Streja E, Kalantar-Zadeh K, Kovesdy CP. Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis. J Am Soc Nephrol 2021:ASN. [PMID: 33547216 DOI: 10.1681/ASN.2020081120] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Sumida K, Lau WL, Kalantar-Zadeh K, Kovesdy CP. Novel intestinal dialysis interventions and microbiome modulation to control uremia. Curr Opin Nephrol Hypertens 2022;31:82-91. [PMID: 34846313 DOI: 10.1097/MNH.0000000000000753] [Reference Citation Analysis]
23 Yang S, Yu C, Guo Y, Bian Z, Fan M, Yang L, Du H, Chen Y, Yan S, Zang Y, Chen J, Chen Z, Lv J, Li L; China Kadoorie Biobank Collaborative Group. Bowel movement frequency and risks of major vascular and non-vascular diseases: a population-based cohort study among Chinese adults. BMJ Open 2020;10:e031028. [PMID: 31924633 DOI: 10.1136/bmjopen-2019-031028] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Prokopienko AJ, Nolin TD. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease. Expert Rev Clin Pharmacol 2018;11:71-82. [PMID: 28905671 DOI: 10.1080/17512433.2018.1378095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
25 Matsushita K, Sang Y, Yang C, Ballew SH, Grams ME, Coresh J, Molnar MZ. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans. PLoS One 2019;14:e0219899. [PMID: 31393910 DOI: 10.1371/journal.pone.0219899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Lu CY, Chen YC, Lu YW, Muo CH, Chang RE. Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease. BMC Nephrol 2019;20:304. [PMID: 31382927 DOI: 10.1186/s12882-019-1481-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Richards EM, Pepine CJ, Raizada MK, Kim S. The Gut, Its Microbiome, and Hypertension. Curr Hypertens Rep 2017;19:36. [PMID: 28444579 DOI: 10.1007/s11906-017-0734-1] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]